• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Biostatistics . A Bayesian approach to estimating COVID-19 incidence and infection fatality rates

tetano

Editor, Senior Moderator
Biostatistics


. 2023 Mar 6;kxad003.
doi: 10.1093/biostatistics/kxad003. Online ahead of print.
A Bayesian approach to estimating COVID-19 incidence and infection fatality rates


Justin J Slater[SUP] 1 [/SUP], Aiyush Bansal[SUP] 2 [/SUP], Harlan Campbell[SUP] 3 [/SUP], Jeffrey S Rosenthal[SUP] 1 [/SUP], Paul Gustafson[SUP] 3 [/SUP], Patrick E Brown[SUP] 4 [/SUP]



Affiliations

Abstract

Naive estimates of incidence and infection fatality rates (IFR) of coronavirus disease 2019 suffer from a variety of biases, many of which relate to preferential testing. This has motivated epidemiologists from around the globe to conduct serosurveys that measure the immunity of individuals by testing for the presence of SARS-CoV-2 antibodies in the blood. These quantitative measures (titer values) are then used as a proxy for previous or current infection. However, statistical methods that use this data to its full potential have yet to be developed. Previous researchers have discretized these continuous values, discarding potentially useful information. In this article, we demonstrate how multivariate mixture models can be used in combination with post-stratification to estimate cumulative incidence and IFR in an approximate Bayesian framework without discretization. In doing so, we account for uncertainty from both the estimated number of infections and incomplete deaths data to provide estimates of IFR. This method is demonstrated using data from the Action to Beat Coronavirus erosurvey in Canada.

Keywords: Bayesian analysis; COVID-19; Mixture model; Modular inference; Post-stratification.
 
Back
Top Bottom